ProZ-UCNCT06642883
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Evaluation of the gut microbiota composition variation (microbiota test)
Timeframe: From enrollment to the end of treatment 8 weeks
Secondary (1)
Evaluation of gut microbiota pathways variation ( Picrust analysis)
Arms and interventions
Prolife 10 ForteActive comparator
Treatment: 1 dose/die (contains 10 ml with: in particular, 7 strains of Lactobacillus (L. casei R215, L. plantarum Lp-115, L. helveticus R0052, L. acidophilus La-14, L. gasseri Lg-36, L. brevis Lbr-35, L. rhamnosus HN001), 2 strains of Bifidobacteria (B. lactis Bl-04 and HN019) and Bacillus coagulans BC4. In addition, it contains 10 mg of glucoligosaccharide and a pool of Vitamin B (B1, B2, B6, B12).
PlaceboPlacebo comparator
Treatment 1dose/die ( All additional components except probiotics and vitamins)
Dietary supplements: Prolife, Placebo
Sites
1 site in 1 country
- Edoardo Vincenzo SavarinoPadua, Padua, Italy